Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People diagnosed with pigmentary glaucoma, showing typical signs such as pigment dispersion in the eye, significant pigment buildup in the eye's drainage tissue, raised eye pressure, damage to the optic nerve, and specific changes in vision
- People whose first and only surgical treatment was a specific eye procedure called ab-interno 120° trabeculotomy (a type of minimally invasive drainage surgery)
- People who have complete records of eye examinations from before and after their surgery, including eye pressure measurements, visual field tests, and scans of the nerve fibre layer at the back of the eye
- People who are able to attend regular check-up appointments for at least 6 months after their surgery
Who may not be able to join:
- People who have exfoliation syndrome, exfoliative glaucoma, or any other type of glaucoma that is not pigmentary glaucoma
- People with a history of eye injury, previous eye surgery, eye inflammation, serious retinal disease, or other eye conditions that could affect eye pressure or vision assessments
- People whose surgery also included additional procedures, such as cataract removal or other glaucoma operations performed at the same time
- People with serious general health conditions, or cognitive or mental health difficulties that would make it hard to cooperate with examinations and follow-up visits
- People whose medical or follow-up records are incomplete in ways that would prevent the trial team from properly assessing treatment outcomes
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Wen Zeng, doctor, Zhongnan Hospital
Phone: 18672395959
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change in Intraocular Pressure (IOP) at 6 Months Postoperatively; Change in the Number of Intraocular Pressure-Lowering Medications at 6 Months
Can't join this trial?
Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.